CVERGENX, INC.
Software platform that integrates biological data and modeling to optimize radiation therapy treatment planning and delivery
- Sector
- Medtech
- Headquarters
- ST. PETERSBURG, FL
- Founded
- 2009
- Latest Form D
- $2.5M offered, Jul 2017
- Total capital
- $616K
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $616K
- 4 Form D · last Jul 2017
- 111 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 4 pending · first 2023
Capital timeline
Latest events
- Offering registeredForm D · SEC · 4th filing$2.5M
- Offering registeredForm D · SEC · 3rd filing$500K
- Private capital raisedForm D · SEC · 2nd filing$390K
- Private capital raisedForm D · SEC · 1st filing$226K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing in Medtech · 4531 companies
Line = median- Federal contractsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Javier F. Torres-Roca, M.D.Executive Officer, DirectorNamed in SEC Form D filings
- Mary Del BradyExecutive Officer, DirectorNamed in SEC Form D filings
- MaryDel F. BradyDirectorNamed in SEC Form D filings
- Raymond F. VennareExecutive Officer, DirectorNamed in SEC Form D filings
- Steven F. Eschrich, Ph.D.Executive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 7- GrantedSystems And Methods For Personalized Radiation TherapyUSPTOUS 12,226,655
- GrantedSystems And Methods For Personalized Radiation TherapyUSPTOUS 11,865,365
- GrantedSystems And Methods For Personalized Radiation TherapyUSPTOUS 11,547,871
Show all 7 patent records
- Systems And Methods For Personalized Radiation TherapyFeb 18, 2025 · US 12,226,655Granted
- Systems And Methods For Personalized Radiation TherapyJan 9, 2024 · US 11,865,365Granted
- Systems And Methods For Personalized Radiation TherapyJan 10, 2023 · US 11,547,871Granted
- Predetermined Genomic Adjusted Radiation Dose (gard) Values For Nasopharyngeal And Oropharyngeal CancersApplication 63578115Pending
- Predetermined Genomic Adjusted Radiation Dose (gard) Values For Nasopharyngeal And Oropharyngeal CancersApplication PCTUS2024043451Pending
- Systems And Methods For Personalized Radiation TherapyApplication PCTUS2019057230Pending
- Predetermined Genomic Adjusted Radiation Dose (gard) Values For Nasopharyngeal And Oropharyngeal CancersApplication 19512986Pending
Related companies, and why
- Beyond Air, Inc.Similar federal contract value in Medtech · null in contracts
- Wincs International, LLCSimilar federal contract value in Medtech · null in contracts
- Sense Diagnostics, LLCSimilar federal contract value in Medtech · null in contracts
- PREMITEC, INC.Similar federal contract value in Medtech · null in contracts
- Alveo Technologies Inc.Similar federal contract value in Medtech · null in contracts
- WaveFront Dynamics Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .